Sarepta Therapeutics Ownership | Who Owns Sarepta Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Sarepta Therapeutics Ownership Summary


Sarepta Therapeutics is owned by 103.21% institutional investors, 4.93% insiders. Tudor investment corp et al is the largest institutional shareholder, holding 70.23% of SRPT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.09% of its assets in Sarepta Therapeutics shares.

SRPT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSarepta Therapeutics103.21%4.93%-8.14%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tudor investment corp et al68.83M70.23%$63.35M
Blackrock funding, inc. /de18.99M18.09%$341.34M
Vanguard group11.81M11.78%$254.17M
Blackrock10.32M10.98%$1.63B
State street8.92M8.49%$160.22M
Two sigma investments, lp4.60M4.38%$82.64M
Vanguard capital management4.59M4.37%$82.51M
First trust advisors lp4.37M4.16%$78.46M
Aqr capital management4.33M4.12%$76.87M
Geode capital management2.77M2.64%$49.82M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Boxer capital650.00K5.41%$102.70M
Ghost tree capital55.00K2.72%$8.69M
Lion point capital, lp28.50K2.45%$512.14K
One68 global capital25.17K2.12%$975.42K
Opaleye management585.00K1.59%$11.27M
Union square park capital management105.00K0.72%$2.02M
683 capital management782.50K0.69%$14.06M
Hussman strategic advisors147.00K0.61%$2.64M
Adar1 capital management730.65K0.60%$13.13M
Corton capital12.02K0.57%$231.63K

Top Buyers

HolderShares% AssetsChange
Tudor investment corp et al68.83M0.11%68.78M
Blackrock10.32M0.04%4.36M
Blackrock funding, inc. /de18.99M0.01%4.24M
State street8.92M0.00%2.30M
Marshall wace, llp2.21M0.03%1.48M

Top Sellers

HolderShares% AssetsChange
Ra capital management---3.90M
Avoro capital advisors---2.67M
Wellington management group llp---2.53M
Farallon capital management---2.34M
Aqr capital management4.33M0.03%-2.11M

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company980.32K0.00%980.32K$17.62M
Qube research609.80K0.01%609.80K$10.96M
Casdin capital470.00K0.42%470.00K$8.45M
Assenagon asset management454.38K0.01%454.38K$8.17M
Panagora asset management451.87K0.02%451.87K$8.12M

Sold Out

HolderChange
Harbor investment advisory-1.00
Bokf, na-1.00
Advisornet financial-1.00
Financial gravity asset management-1.00
Private wealth asset management-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026343-6.79%108,359,0275.33%1031.07%150-3.23%115-13.53%
Mar 31, 2026358-7.25%99,855,7286.90%951.10%149-26.60%13036.84%
Dec 31, 2025198-45.45%44,714,234-48.61%440.57%113-35.43%39-62.86%
Sep 30, 2025163-60.63%42,318,819-50.10%430.58%77-65.47%57-36.67%
Jun 30, 2025410-12.02%84,724,983-2.96%861.07%2222.30%89-42.58%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF6.43M6.09%4.42K
First Trust NYSE Arca Biotech ETF4.80M4.55%-43.83K
State Street® SPDR® S&P® Biotech ETF4.38M4.15%10.06K
iShares Core S&P Mid-Cap ETF3.20M3.28%-5.78K
American Funds Growth Fund of Amer A3.15M3.25%-5.26K
Capital Group Growth Fnd of Amer Comp3.15M3.21%-5.26K
Vanguard MStar Total Stk Mkt Idx Invest3.19M3.02%5.82K
Vanguard Total Stock Mkt Idx Inv3.19M3.02%3.37K
Vanguard Morn Total Stk Mkt Idx Investor3.19M3.02%3.37K
Vanguard US Total Market Shares ETF2.85M2.94%2.16K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 12, 2026Mayo Stephen-Sell$123.21K
Dec 16, 2025Estepan Ian Michael Chief Operating OfficerSell$294.20K
Mar 12, 2025Nicaise Claude-Sell$248.20K
Dec 12, 2024Wigzell Hans Lennart Rudolf-Sell$1.31M
Dec 05, 2024Boor Kathryn Jean-Sell$205.40K

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q2--
2026 Q1-1
2025 Q3--
2025 Q2--

SRPT Ownership FAQ


Who Owns Sarepta Therapeutics?

Sarepta Therapeutics shareholders are primarily institutional investors at 103.21%, followed by 4.93% insiders and -8.14% retail investors. The average institutional ownership in Sarepta Therapeutics's industry, Biotech Stocks , is 379.61%, which Sarepta Therapeutics falls below.

Who owns the most shares of Sarepta Therapeutics?

Sarepta Therapeutics’s largest shareholders are Tudor investment corp et al (68.83M shares, 70.23%), Blackrock funding, inc. /de (18.99M shares, 18.09%), and Vanguard group (11.81M shares, 11.78%). Together, they hold 100.11% of Sarepta Therapeutics’s total shares outstanding.

Does Blackrock own Sarepta Therapeutics?

Yes, BlackRock owns 10.98% of Sarepta Therapeutics, totaling 10.32M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.63B$. In the last quarter, BlackRock increased its holdings by 4.36M shares, a 73.22% change.

Who is Sarepta Therapeutics’s biggest shareholder by percentage of total assets invested?

Boxer capital is Sarepta Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.41% of its assets in 650K Sarepta Therapeutics shares, valued at 102.7M$.

Who is the top mutual fund holder of Sarepta Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Sarepta Therapeutics shares, with 6.09% of its total shares outstanding invested in 6.43M Sarepta Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools